ArticleAntibiotics (Basel, Switzerland)2026
Characterization of an
Qingyuan Zhang, Xiaohong Xie, Lixin Tao, Jian Wang, Yuan Shi, Huangfei Sheng, Chuanlong Liu, Hongwei Zhao, Meihua Liu, Jun Feng
Abstract read
In one paragraphArticle in Antibiotics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Qingyuan ZhangShanghai Fengxian Center for Disease Control and Prevention, Shanghai Fengxian Health Supervision Institute, Shanghai 201499, China.ORCID 0000-0002-4611-2468 Xiaohong XieShanghai Fengxian Center for Disease Control and Prevention, Shanghai Fengxian Health Supervision Institute, Shanghai 201499, China.
Lixin TaoShanghai Fengxian Center for Disease Control and Prevention, Shanghai Fengxian Health Supervision Institute, Shanghai 201499, China.
Jian WangShanghai Fengxian Center for Disease Control and Prevention, Shanghai Fengxian Health Supervision Institute, Shanghai 201499, China.
Yuan ShiShanghai Fengxian Center for Disease Control and Prevention, Shanghai Fengxian Health Supervision Institute, Shanghai 201499, China.
Huangfei ShengShanghai Fengxian Center for Disease Control and Prevention, Shanghai Fengxian Health Supervision Institute, Shanghai 201499, China.
Chuanlong LiuShanghai Fengxian Center for Disease Control and Prevention, Shanghai Fengxian Health Supervision Institute, Shanghai 201499, China.
Hongwei ZhaoShanghai Fengxian Center for Disease Control and Prevention, Shanghai Fengxian Health Supervision Institute, Shanghai 201499, China.
Meihua LiuShanghai Fengxian Center for Disease Control and Prevention, Shanghai Fengxian Health Supervision Institute, Shanghai 201499, China.
Funding
The Science And Technology Development Fund (Social Sector) Of Fengxian, Shanghai No. 20250806
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
blaNDM-5Escherichia coliIncHI2mcr-1.1urban WWTPs
Identifiers
PMID41892436
PMCPMC13024088
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390